Diclofenac rectal - CeNeS

Drug Profile

Diclofenac rectal - CeNeS

Alternative Names: Diclofenac Hycore-R

Latest Information Update: 12 Sep 2002

Price : $50

At a glance

  • Originator CeNeS Pharmaceuticals
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Postoperative pain

Most Recent Events

  • 12 Sep 2002 Discontinued - Phase-I for Postoperative pain in United Kingdom (Rectal)
  • 16 Dec 1999 Core Group has merged with CeNeS Limited to form CeNeS Pharmaceuticals
  • 30 Apr 1998 Phase-I clinical trials for Postoperative pain in United Kingdom (Rectal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top